title: A low fixed dose of prothrombin complex concentrate is cost effective in emergency reversal of vitamin K antagonists.
authors: Nakisa
authors: N
authors: Khorsand
authors: Lisette
authors: L
authors: Giepmans
authors: Karina
authors: K
authors: Meijer
authors: Reinier M
authors: RM
authors: van Hest
authors: Nic J G M
authors: NJ
authors: Veeger
mesh_terms: D001779:Blood Coagulation Factors / Q000008:administration & dosage* / Q000191:economics; D003362:Cost-Benefit Analysis; D006470:Hemorrhage / Q000139:chemically induced* / Q000628:therapy*; D006801:Humans; D015233:Models, Statistical; D014812:Vitamin K / Q000037:antagonists & inhibitors*
chemical_list: D001779:Blood Coagulation Factors; D014812:Vitamin K; C025667:prothrombin complex concentrates
keywords: anticoagulation; bleeding complication; cost-effectiveness; prothrombin complex concentrate; reversal; vitamin K antagonist reversal
references: Transfus Med. 2011 Apr;21(2):116-23
references: 21073580
references: Chest. 2012 Feb;141(2 Suppl):53S-70S
references: 22315256
references: Haematologica. 2012 Oct;97(10):1501-6
references: 22491734
references: Int J Technol Assess Health Care. 2012 Apr;28(2):152-8
references: 22559757